News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current TELO market cap is 8.95M. The company's latest EPS is CAD -0.0364 and P/E is -3.30.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.31M | -1.26M | -2.11M | -2.82M | -2.72M |
| Net Income | -1.24M | -1.07M | -2.11M | -2.82M | -2.71M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.17M | 3.84M | 2.83M | 2.93M | 965k |
| Total Liabilities | 393k | 154k | 230k | 313k | 375k |
| Total Equity | 775k | 3.69M | 2.6M | 2.61M | 590k |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.12M | -1.11M | -1.8M | -2.63M | -2.46M |
| Investing | -8k | -9k | -25k | -69k | -5k |
| Financing | 2.03M | 3.83M | 876k | 2.68M | 587k |
| Market Cap | 8.95M |
| Price to Earnings Ratio | -3.30 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.21 |
| Price to Book Ratio | 15.16 |
| Dividend Yield | - |
| Shares Outstanding | 74.56M |
| Average Volume (1 week) | 71.2k |
| Average Volume (1 Month) | 69.79k |
| 52 Week Change | -33.33% |
| 52 Week High | 0.23 |
| 52 Week Low | 0.10 |
| Spread (Intraday) | 0.01 (4.17%) |
| Company Name | Telo Genomics Corporation |
| Address |
1200-750 west pender st vancouver, british columbia V6C 2T8 |
| Website | https://www.telodx.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
